Discover 1,087 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oregon provides numerous opportunities for both healthy volunteers and individuals with specific health conditions to get involved in paid medical research. With major research centers in Portland, Eugene, and Salem actively recruiting, participants can access the latest in treatment options and medical innovation.
Filter
1
Filter results
Results: 1,087
OCT in Diagnosis of Irregular Corneas
for
Keratoconus, Corneal Opacity, Corneal Dystrophy
Location: Portland OR
Sponsor: Oregon Health and Science University
Sex: All
Age: 14 - 70+
Code: NCT03504800
Recruiting
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
for
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,
Location: New York NY, Richmond VA, Webster NY, Rochester NY,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05890352
Phase 2, Recruiting
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
for
Cystic Fibrosis
Location: Boston MA, Burlington VT, Philadelphia PA, Baltimore MD,
Sponsor: University of Washington, the Collaborative Health Studies Coordinating Center
Sex: All
Age: 3 - 18
Code: NCT06654752
Recruiting
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
for
Acute Monocytic Leukemia, Acute Myeloid Leukemia
Location: Miami FL, Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT06504459
Phase 2, Recruiting
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors